Compare Stocks → World’s biggest multibillionaire investor is buying THIS by the ton [picture] (From Stansberry Research) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison CNSX:ASENYSE:HAVNYSE:PMC Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeASEAsante GoldC$0.00C$0.05▼C$0.18N/AN/AN/A1,000 shsHAVHelios Advantage Income Fund$0.00$0.00▼$0.00N/AN/AN/AN/APMCPharmerica$0.00$22.00▼$29.50N/AN/A283,015 shsN/A7 Stocks to Own Before the 2024 ElectionLooking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceASEAsante Gold0.00%0.00%0.00%0.00%0.00%PMCPharmerica0.00%0.00%0.00%0.00%0.00%World’s biggest multibillionaire investor is buying THIS by the ton [picture] (Ad)Don't Buy Bullion or Mining Stocks. Do THIS Instead As gold continues to break all-time highs, many folks will run out and buy bullion or mining stocks. That's not the best way to ride this gold bull market higher. Note, this showed a 995% gain the last time we shared this same investment idea.Click here to find out what to do.MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationASEAsante GoldN/AN/AN/AN/AN/AN/AN/AN/AHAVHelios Advantage Income FundN/AN/AN/AN/AN/AN/AN/AN/APMCPharmericaN/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceASEAsante GoldN/AN/AN/AN/AHAVHelios Advantage Income FundN/AN/AN/AN/APMCPharmericaN/AN/AN/AN/ASales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookASEAsante GoldN/AN/AN/AN/AN/AN/AHAVHelios Advantage Income FundN/AN/AN/AN/AN/AN/APMCPharmericaN/AN/AN/AN/AN/AN/AProfitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateASEAsante GoldN/AN/A0.00N/AN/AN/AN/AN/AN/AHAVHelios Advantage Income FundN/AN/A0.00N/AN/AN/AN/AN/AN/APMCPharmericaN/AN/A0.00N/AN/AN/AN/AN/AN/ADividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthASEAsante GoldN/AN/AN/AN/AN/AHAVHelios Advantage Income FundN/AN/AN/AN/AN/APMCPharmericaN/AN/AN/AN/AN/AOwnershipInstitutional OwnershipCompanyInstitutional OwnershipASEAsante GoldN/AHAVHelios Advantage Income FundN/APMCPharmerica89.97%Insider OwnershipCompanyInsider OwnershipASEAsante GoldN/AHAVHelios Advantage Income FundN/APMCPharmerica5.04%MiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableASEAsante GoldN/AN/AN/ANot OptionableHAVHelios Advantage Income FundN/AN/AN/ANot OptionablePMCPharmericaN/AN/AN/ANot OptionablePMC, ASE, HAV, and PGO HeadlinesSourceHeadlineMedicine shortage hits TB elimination programme in Punemsn.com - March 30 at 4:53 PMFrom next month, PMC hospitals, maternity homes to get generic medicine storesmsn.com - November 22 at 6:36 AMDavenport Extreme Pools & Spas owner and spouse charged with fraud, theftbizjournals.com - October 6 at 6:03 PMPMC Prodigy 1 reviewwhathifi.com - September 14 at 10:50 PMPharmerica Stock Falls On Unusually High Volume (PMC)thestreet.com - May 25 at 8:22 AMTop Stories: Patient information exposed in PharMerica breachhealthcarefinancenews.com - May 24 at 8:39 PMPharMerica Notifies 5.8M Individuals of Healthcare Data Breachhealthitsecurity.com - May 19 at 12:25 PMActivities of Daily Living for Seniorshealth.usnews.com - April 20 at 2:20 AMWe can howl about staffing challenges, or start fixing themmcknights.com - April 18 at 12:13 AMPAC Profile: Pharmerica Corpopensecrets.org - April 18 at 12:13 AMGolden Livingforbes.com - February 24 at 12:56 AMGas Cylinders Market Size in 2023 | Worldwide Industry Outlook, COVID-19 Impact, Market Trends, Share, Top Countries Data | Forecast Till 2028marketwatch.com - January 17 at 9:51 AMKentucky orthopedic practice to relocatebeckersspine.com - December 27 at 2:02 PMGas Cylinders Market is Estimated to Accelerate Industry Development in Machinery & Equipment Sector with Top Key Players till 2028marketwatch.com - November 10 at 9:28 PM9 Medford Residents To Participate In 2022 Pan-Mass Challengemsn.com - July 15 at 3:50 PMZero tolerance policy on irregularities in medical education system: PMCapp.com.pk - June 25 at 1:10 PMPMC among nation’s top-performing hospitals for treatment of heart attack patientsnews-expressky.com - May 25 at 7:28 PMCVS Health Will Buy Pharmacy Benefits Manager Omnicare for $12.7Bthestreet.com - January 21 at 8:53 PMView | PMC Bank rescue blueprint: let bail-in not be resurrected surreptitiouslymsn.com - December 8 at 1:05 PMTop Headlines3 Value Stocks Too Small For Buffett’s PortfolioMarch 28, 2024 12:16 PMView 3 Value Stocks Too Small For Buffett’s PortfolioPagaya Technologies: An AI Fintech That Insiders Are BuyingApril 24, 2024 11:12 AMView Pagaya Technologies: An AI Fintech That Insiders Are BuyingHow to Protect your Portfolio Against a Rising VIXApril 10, 2024 9:22 AMView How to Protect your Portfolio Against a Rising VIXBreakout Alert: Coinbase's Consolidation Is About To EndApril 12, 2024 9:45 AMView Breakout Alert: Coinbase's Consolidation Is About To End3 Energy Stocks to Consider as the Sector Breaks OutApril 8, 2024 8:55 AMView 3 Energy Stocks to Consider as the Sector Breaks OutAll Headlines Company DescriptionsAsante GoldCNSX:ASEAsante Gold Corporation, a mineral exploration company, engages in the acquisition, exploration, and development of mineral resource properties in the Republic of Ghana. It holds 100% interest in the Fahiakoba concession situated in the Ashanti and Central regions in the Republic of Ghana; and 90% interest in the Bibiani gold mine located in the western region of Ghana. The company also has an option to acquire a 100% interest in the Betenase permit located in Ghana; 90% interest in the Kubi Mining lease located in southwest Ghana; and 100% interest in the Keyhole Gold project. Asante Gold Corporation was incorporated in 2011 and is based in Vancouver, Canada.Helios Advantage Income FundNYSE:HAVHelios Advantage Income Fund, Inc. (the Fund) is a diversified, closed-end management investment company. The Fund seeks a high level of current income. The Fund seeks capital growth as a secondary investment objective. It invests a majority of its total assets in below-investment-grade debt securities. The Fund also may invest in investment grade debt securities, up to 15% of its total assets in foreign debt and foreign equity securities, and up to 25% of its total assets in domestic equity securities, including common and preferred stocks. The Fund invests in a range of below-investment-grade debt securities, including corporate bonds, mortgage-backed and asset-backed securities, and municipal and foreign government obligations, as well as securities of companies in bankruptcy reorganization proceedings or otherwise in the process of debt restructuring. The Fund's investment advisor is Brookfield Investment Management Inc.PharmericaNYSE:PMCPharMerica Corporation is an institutional pharmacy services company. The Company services healthcare facilities, provides pharmacy management services to hospitals and specialty infusion services to patients outside a hospital setting, and offers the national oncology pharmacy in the United States. Its segments include institutional pharmacy, which provides pharmacy products and services to residents and patients in skilled nursing facilities, nursing centers, assisted living facilities, hospitals and other long-term alternative care settings; specialty infusion services, which provides specialty infusion services focused on providing pharmaceutical products and clinical services to patients in client facilities, hospice and outside of hospital or nursing home settings, and specialty oncology pharmacy, which provides dispensing of oncology drugs, care management and other related services to patients, oncology practices and hospitals. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.